Lourdes Mozo

1.1k total citations
26 papers, 867 citations indexed

About

Lourdes Mozo is a scholar working on Immunology, Rheumatology and Epidemiology. According to data from OpenAlex, Lourdes Mozo has authored 26 papers receiving a total of 867 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 13 papers in Rheumatology and 7 papers in Epidemiology. Recurrent topics in Lourdes Mozo's work include Systemic Lupus Erythematosus Research (11 papers), T-cell and B-cell Immunology (5 papers) and Immune Cell Function and Interaction (4 papers). Lourdes Mozo is often cited by papers focused on Systemic Lupus Erythematosus Research (11 papers), T-cell and B-cell Immunology (5 papers) and Immune Cell Function and Interaction (4 papers). Lourdes Mozo collaborates with scholars based in Spain, South Africa and Italy. Lourdes Mozo's co-authors include Ana Suárez, Carmen Gutiérrez, Patricia Garrido Castro, Rebeca Alonso‐Arias, Luis Caminal‐Montero, Patricia López, J.M. Fernández Gómez, Javier Rodríguez‐Carrio, Carlos Lahoz and Alberto Hidalgo Tuñón and has published in prestigious journals such as The Journal of Immunology, Scientific Reports and Journal of Allergy and Clinical Immunology.

In The Last Decade

Lourdes Mozo

25 papers receiving 847 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lourdes Mozo Spain 17 494 298 142 130 107 26 867
Youssef M. Mosaad Egypt 20 400 0.8× 248 0.8× 121 0.9× 171 1.3× 99 0.9× 56 941
Guadalupe Lima Mexico 19 429 0.9× 266 0.9× 87 0.6× 140 1.1× 171 1.6× 54 821
Wahiba Chaara France 13 630 1.3× 183 0.6× 128 0.9× 158 1.2× 106 1.0× 15 1.0k
Lilian Soto Chile 18 602 1.2× 387 1.3× 91 0.6× 141 1.1× 155 1.4× 32 1.1k
Amalia Raptopoulou Greece 12 540 1.1× 444 1.5× 98 0.7× 142 1.1× 182 1.7× 16 979
Catherine H. Orteu United Kingdom 17 419 0.8× 193 0.6× 155 1.1× 101 0.8× 77 0.7× 32 943
Hitoshi Ogasawara Japan 19 368 0.7× 342 1.1× 116 0.8× 229 1.8× 120 1.1× 55 933
Nancy Solowski United States 7 261 0.5× 205 0.7× 124 0.9× 113 0.9× 66 0.6× 11 699
Raquel Castejón Spain 16 644 1.3× 196 0.7× 104 0.7× 133 1.0× 130 1.2× 49 995
Ibtissem Ghédira Tunisia 18 251 0.5× 276 0.9× 241 1.7× 92 0.7× 66 0.6× 70 885

Countries citing papers authored by Lourdes Mozo

Since Specialization
Citations

This map shows the geographic impact of Lourdes Mozo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lourdes Mozo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lourdes Mozo more than expected).

Fields of papers citing papers by Lourdes Mozo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lourdes Mozo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lourdes Mozo. The network helps show where Lourdes Mozo may publish in the future.

Co-authorship network of co-authors of Lourdes Mozo

This figure shows the co-authorship network connecting the top 25 collaborators of Lourdes Mozo. A scholar is included among the top collaborators of Lourdes Mozo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lourdes Mozo. Lourdes Mozo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rodríguez‐Carrio, Javier, Lourdes Mozo, Patricia López, Elena Nikiphorou, & Ana Suárez. (2018). Anti-High-Density Lipoprotein Antibodies and Antioxidant Dysfunction in Immune-Driven Diseases. Frontiers in Medicine. 5. 114–114. 12 indexed citations
3.
López, Patricia, Javier Rodríguez‐Carrio, Aleida Martínez Zapico, et al.. (2017). Serum Levels of Anti-PON1 and Anti-HDL Antibodies as Potential Biomarkers of Premature Atherosclerosis in Systemic Lupus Erythematosus. Thrombosis and Haemostasis. 117(11). 2194–2206. 28 indexed citations
4.
Cabezas‐Rodríguez, Iván, et al.. (2016). Anti-MDA5 dermatomyositis mimicking psoriatic arthritis. Reumatología Clínica. 14(4). 224–226. 6 indexed citations
5.
López‐Vázquez, Antonio, Lourdes Mozo, Rebeca Alonso‐Arias, et al.. (2014). Autoantibodies against MHC class I polypeptide-related sequence A are associated with increased risk of concomitant autoimmune diseases in celiac patients. BMC Medicine. 12(1). 34–34. 3 indexed citations
6.
Caminal‐Montero, Luis, et al.. (2013). Common and Specific Associations of Anti‐SSA/Ro60 and Anti‐Ro52/TRIM21 Antibodies in Systemic Lupus Erythematosus. The Scientific World JOURNAL. 2013(1). 832789–832789. 35 indexed citations
7.
Caminal‐Montero, Luis, et al.. (2012). Clinical associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies: Diagnostic utility of their separate detection. Autoimmunity. 46(1). 32–39. 57 indexed citations
8.
Mozo, Lourdes, et al.. (2011). Diagnostic Value of Anti‐deamidated Gliadin Peptide IgG Antibodies for Celiac Disease in Children and IgA‐deficient Patients. Journal of Pediatric Gastroenterology and Nutrition. 55(1). 50–55. 33 indexed citations
9.
Paz, Banesa de, Mercedes Alperí, Francisco Javier Ballina‐García, et al.. (2010). Interleukin 10 and Tumor Necrosis Factor-α Genotypes in Rheumatoid Arthritis — Association with Clinical Response to Glucocorticoids. The Journal of Rheumatology. 37(3). 503–511. 20 indexed citations
10.
Mozo, Lourdes, Carmen Gutiérrez, & J.M. Fernández Gómez. (2008). Antibodies to Mitotic Spindle Apparatus: Clinical Significance of NuMA and HsEg5 Autoantibodies. Journal of Clinical Immunology. 28(4). 285–290. 16 indexed citations
11.
Castro, Patricia Garrido, Ana Suárez, Lourdes Mozo, & Carmen Gutiérrez. (2006). Association of IL-10 and TNFα genotypes with ANCA appearance in ulcerative colitis. Clinical Immunology. 122(1). 108–114. 8 indexed citations
12.
Gómez, J.M. Fernández, et al.. (2006). Systemic Lupus Erythematosus in Asturias, Spain. Medicine. 85(3). 157–168. 36 indexed citations
13.
Castro, Patricia Garrido, Lourdes Mozo, Carmen Gutiérrez, & Ana Suárez. (2006). TNFα genotype influences development of IgA-ASCA antibodies in Crohn's disease patients with CARD15 wild type. Clinical Immunology. 121(3). 305–313. 5 indexed citations
14.
Castro, Patricia Garrido, et al.. (2006). TNFalpha and IL-10 Gene Polymorphisms in Inflammatory Bowel Disease. Association of -1082 AA Low Producer IL-10 Genotype with Steroid Dependency. The American Journal of Gastroenterology. 101(5). 1039–1047. 46 indexed citations
15.
López, Patricia, J.M. Fernández Gómez, Lourdes Mozo, Carmen Gutiérrez, & Ana Suárez. (2006). Cytokine polymorphisms influence treatment outcomes in SLE patients treated with antimalarial drugs. Arthritis Research & Therapy. 8(2). R42–R42. 31 indexed citations
16.
Mozo, Lourdes, et al.. (2000). Long-term effect of IFNβ1b treatment on the spontaneous and induced expression of IL-10 and TGFβ1 in MS patients. Journal of the Neurological Sciences. 179(1-2). 43–49. 12 indexed citations
17.
Mozo, Lourdes, et al.. (1998). Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse. Journal of Neuroimmunology. 85(2). 122–130. 77 indexed citations
18.
Mozo, Lourdes, et al.. (1998). Glucocorticoids inhibit IL-4 and mitogen-induced IL-4Rα chain expression by different posttranscriptional mechanisms☆☆☆★★★♢. Journal of Allergy and Clinical Immunology. 102(6). 968–976. 38 indexed citations
19.
20.
Mozo, Lourdes, et al.. (1995). Upregulated expression of IL-4 receptors and increased levels of IL-4 in rheumatoid arthritis patients. Journal of Autoimmunity. 8(4). 587–600. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Youssef M. Mosaad Breakdown of academic impact, for papers by Guadalupe Lima Breakdown of academic impact, for papers by Wahiba Chaara Breakdown of academic impact, for papers by Lilian Soto Breakdown of academic impact, for papers by Amalia Raptopoulou Breakdown of academic impact, for papers by Catherine H. Orteu Breakdown of academic impact, for papers by Hitoshi Ogasawara Breakdown of academic impact, for papers by Nancy Solowski Breakdown of academic impact, for papers by Raquel Castejón Breakdown of academic impact, for papers by Ibtissem Ghédira
Rankless by CCL
2026